β-alanine in the Treatment of Advanced Hepatocellular Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is a prospective, randomized controlled study on nutritional support and metabolic regulation. It assesses the safety, compliance, and improvement of metabolic/physical-related indicators when using β-alanine within the specified dose range as dietary supplementation, in addition to the standard first-line treatment. The anti-tumor efficacy (ORR, PFS, OS) is the exploratory endpoint.
Epistemonikos ID: af08fd32ec52b72dec806fc0704684e19cc2b346
First added on: Jan 06, 2026